Monday, August 15, 2011 9:20:32 PM
The stock is selling for less than cash in the bank, with a sort of limbo (but not looked at all good) status on the current drug application. FDA says they need to redo the trials (OUCH). They still have 2 other drugs in the pipeline, but all will burn cash at this point, so cash value per share is going to go down, or share count will rise soon. Someone posted some info on the ANX COB (seems he is also the COB of another biotech that is being sued for defrauding investors).
I am still holding all my shares. No sense selling here.
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM